| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Polarean: Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026 | 1 | GlobeNewswire (USA) | ||
| 20.01. | Polarean Expands Xenon MRI Platform into Cardiopulmonary Drug Development with Multi-Center PH-ILD Study | 3 | GlobeNewswire (USA) | ||
| 12.01. | Polarean Highlights New CHEST Journal Study Demonstrating Xenon MRI Predicts Cystic Fibrosis Exacerbations | 3 | GlobeNewswire (USA) | ||
| POLAREAN IMAGING Aktie jetzt für 0€ handeln | |||||
| 29.12.25 | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 29.12.2025 | 1.704 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 29.12.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 29.12.2025ISIN NameAU0000111395 PROSPECH... ► Artikel lesen | |
| 24.12.25 | Polarean Imaging and OPG Power Ventures start trading on JP Jenkins | 8 | Alliance News | ||
| 23.12.25 | XFRA 8ZF: AUSSETZUNG/SUSPENSION | 251 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILPOLAREAN IMAG.LS-... ► Artikel lesen | |
| 23.12.25 | AIM - Cancellation - Polarean Imaging Plc | 2 | RNS | ||
| 17.12.25 | FTSE Russell - Polarean Imaging: Constituent Deletion - Changes in FTSE UK Index Series | 2 | RNS | ||
| 15.12.25 | Polarean to delist from AIM following shareholder approval | 3 | Investing.com | ||
| 15.12.25 | Polarean Imaging: Aktionäre stimmen für Delisting vom AIM | 4 | Investing.com Deutsch | ||
| 15.12.25 | Polarean Imaging PLC - Result of General Meeting | 2 | RNS | ||
| 01.12.25 | Polarean: XENOVIEW 3T coil passes Philips compatibility testing | 1 | GlobeNewswire (USA) | ||
| 01.12.25 | Polarean: XENOVIEW-Brustspule mit Philips-MRT-Systemen kompatibel | 12 | Investing.com Deutsch | ||
| 01.12.25 | Polarean's chest coil compatible with Philips MRI systems | 3 | Investing.com | ||
| 01.12.25 | Polarean Imaging PLC - Chest coil passes Philips compatibility testing | 1 | RNS | ||
| 25.11.25 | Polarean Imaging PLC - First Xenon Hyperpolariser in Asia | - | RNS | ||
| 24.11.25 | IN BRIEF: Polarean Imaging signs exclusive Xenon distribution deal | 3 | Alliance News | ||
| 24.11.25 | Polarean: Korean distributor agreement with DK Healthcare in South Korea | 2 | GlobeNewswire (USA) | ||
| 24.11.25 | Polarean Imaging signs distribution deal in South Korea | 1 | Sharecast | ||
| 24.11.25 | Polarean Imaging PLC - Korean distributor agreement with DK Healthcare | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDTRONIC | 65,56 | +0,18 % | Medtronic (MDT) Stock Drops Despite Market Gains: Important Facts to Note | ||
| HCA HEALTHCARE | 360,80 | -1,45 % | ROUNDUP: HCA Healthcare Reaffirms FY26 Outlook; Stock Down 6.8% | WASHINGTON (dpa-AFX) - While reporting financial results for the first quarter on Friday, HCA Healthcare, Inc. (HCA) reaffirmed its earnings and revenue guidance for the full-year 2026.For fiscal... ► Artikel lesen | |
| LANTHEUS | 80,00 | -2,44 % | Mizuho raises Lantheus stock price target to $100 on Q1 beat | ||
| ENVISTA | 20,400 | -1,92 % | Envista Holdings Corporation: Envista Reports First Quarter 2026 Results | BREA, Calif., May 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended April 3, 2026.
"We delivered a good start... ► Artikel lesen | |
| CAREDX | 18,400 | +0,55 % | CareDx, Inc.: CareDx Introduces AlloSeq Nano at EFI 2026, Expanding HLA Typing Portfolio with Long-Read Sequencing | AlloSeq Nano delivers rapid, high-resolution HLA and ABO genotyping in a single assay through a streamlined, long-read workflow designed for transplant and donor typing laboratories.
CareDx, Inc.... ► Artikel lesen | |
| GT BIOPHARMA | 0,327 | +1,24 % | GT Biopharma, Inc.: GT Biopharma Reports Full Year 2025 Financial Results | Phase 1 trial evaluating GTB-3650 TriKE- continues to actively enroll, with the next update anticipated in Q3 2026 following completion of enrollment in dose Cohort 5 Phase 1 basket trial evaluating... ► Artikel lesen | |
| SYNEOS HEALTH | - | - | causaLens Expands Strategic Partnership with Syneos Health to Scale Agentic AI in Biopharma Commercialization | causaLens, a London-based AI scaleup, today announced the expansion of its strategic partnership with Syneos Health, a leading fully integrated biopharmaceutical solutions organization, to advance... ► Artikel lesen | |
| CARMAT | 0,049 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.03.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2026.ISIN NameCA4013392051 GUARDIAN... ► Artikel lesen | |
| CHEMOMETEC | 43,100 | -0,09 % | Chemometec A/S: Growth in revenue and operating profit | Trading statement for Q3 2025/26 (1 January - 31 March 2026) Growth in revenue and operating profit ChemoMetec's revenue was up by 15% in the third quarter of 2025/26 to DKK 142.3 million from DKK... ► Artikel lesen | |
| DEVYSER DIAGNOSTICS | 8,270 | -4,72 % | Devyser Diagnostics AB: Bulletin from the Annual General Meeting of Devyser Diagnostics AB (publ) held on 6 May 2026 | The Annual General Meeting of Devyser Diagnostics AB (publ) ("Devyser" or the "Company") was held on Wednesday, 6 May 2026 at Bränningevägen 12, 120 54 Årsta. The main resolutions passed at the Meeting... ► Artikel lesen | |
| ARRAIL GROUP | 0,203 | -100,00 % | XFRA I1D: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME Waehrung/Currency ISIN BIS/UNTIL
ARRAIL... ► Artikel lesen | |
| FRESENIUS | 39,520 | -0,90 % | EQS-News: Fresenius SE & Co. KGaA: Exzellenter Jahresauftakt: Fresenius zeigt anhaltend operative Stärke und Resilienz; Ausblick bestätigt | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Quartalsergebnis
Exzellenter Jahresauftakt: Fresenius zeigt anhaltend operative Stärke und Resilienz; Ausblick bestätigt (News... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 33,900 | +0,98 % | Siemens Healthineers nach Carve-out Plan: Warum der Konzern jetzt zum strategischen Wendepunkt ansetzt | Siemens Healthineers steht nach der Ankündigung eines Carve-outs einer kleineren Einheit vor einem strategischen Wendepunkt. Die von Seeking Alpha analysierten Pläne zielen darauf ab, die Konzernstruktur... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,660 | +1,05 % | Neue Märkte, erfolgreiche Restrukturierung und Abverkauf - dynaCERT Inc., Fresenius Medical Care, SMA Solar | Die globalen Märkte reagierten gestern sehr dynamisch auf Trumps Pause vom "Project Freedom". Der US-Präsident beendet vorläufig die US-Militärmission zur Begleitung von Handelsschiffen durch die Straße... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 28,720 | +12,36 % | Carl Zeiss Meditec AG: Umstrukturierung überlagert Q2-Verfehlung. Kursziel gesenkt; bleibt HALTEN | Carl Zeiss Meditec (CZM) berichtete über ein schwaches Q2 25/26,. Der Umsatz von 524 Mio. EUR übertraf die Konsensschätzung von 516 Mio. EUR, fiel jedoch um 6,4 % im Vergleich zum Vorjahr. Das EBIT... ► Artikel lesen |